HealthCapital Berlin-Brandenburg

What HealthCapital Berlin-Brandenburg does

HealthCapital Berlin-Brandenburg (officially "Cluster Gesundheitswirtschaft Berlin-Brandenburg") is a publicly-funded cluster management organization dedicated to the healthcare economy of the German capital region. It coordinates, networks, and supports the regional ecosystem across three declared sectors — Biotech & Pharma, Medtech & Digital Health, and Healthcare/Versorgung — and serves a member base of more than 760 actors tracked in its Life Sciences directory, 300+ Berlin biotech companies, and 150 clinics including Charité, Europe's largest university hospital. It does not sell commercial products or charge for its core services: all networking, settlement/expansion consulting, startup support, funding guidance, internationalization services, and event programming are provided free of charge to ecosystem participants. The cluster is jointly operated by Berlin Partner für Wirtschaft und Technologie GmbH (headquartered at Fasanenstrasse 85, 10623 Berlin) and Wirtschaftsförderung Brandenburg (WFBB), with funding from the European Regional Development Fund (EFRE) and the State of Brandenburg.

The organization runs high-visibility events including the BIO International Convention, GITEX AI EUROPE, the Berlin-BIOTECH Symposium, Patient Monitoring Roundtables, Leibniz Symposia, and international delegation trips (e.g., GETA International to Singapore). Its publishing program includes the Life Sciences Report, the Masterplan Gesundheit strategic document, the Digital Health Ökosystem inventory, and the Interstate Health Report combining data from health insurance, pension insurance, and accident insurance providers. Marketing and outreach span the website (healthcapital.de), a LinkedIn showcase page, email newsletters, publications, fact sheets, and international trade show presence. Headcount is reported at 101–250 employees; Dr. Stefan Franzke is listed as CEO and Michael Biel as Acting Executive Chairman of the operating entity, Berlin Partner für Wirtschaft und Technologie GmbH.

Strategically, HealthCapital acts as the connective tissue between research (Charité, Max Delbrück Center, BIH), industry (Bayer's BC GCT cell therapy site, T-knife, EpiBlock, BlueRock Therapeutics, Captain T Cell), clinical infrastructure (150 clinics), and capital. Notable public co-investments include the €100M+ Berlin Center for Gene and Cell Therapies (BC GCT) co-located with Bayer's Berlin campus and the 2025 Helmholtz €30.8M commitment to an AI-accelerated molecular medicine center at MDC. Because services are free and the cluster is publicly funded, HealthCapital itself is not a revenue-generating commercial business; it is best understood as a regional economic development platform whose financial scale is determined by state and EU programmatic budgets routed through its operating entities rather than market-priced services.

Name

HealthCapital Berlin-Brandenburg

Legal name

Berlin Partner für Wirtschaft und Technologie GmbH

Website

https://healthcapital.de

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

HealthCapital Berlin-Brandenburg is a publicly-funded cluster management organization that coordinates the Berlin-Brandenburg healthcare ecosystem across Biotech & Pharma, Medtech & Digital Health, and clinical care, serving 760+ actors including research institutions, startups, clinics, and investors through free networking, settlement consulting, events, and publications.

Ownership category

akta.pro rank

Product category

Healthcare Cluster Management

NAICS

Professional Organizations (813920)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Public Health Governance, Interagency Coordination & Partnerships (HLAJAMAD)

akta.pro secondary industries

Digital Health, Health Information Systems & Data Programs (BPADAIAJ), Health Systems Strengthening & Global Health Technical Assistance (BPADAEAH)

Keywords

• Cluster management services
• Healthcare ecosystem development
• Life sciences networking
• Biotech regional development
• Healthcare innovation support

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

1. Cluster Management Services: HealthCapital Berlin-Brandenburg provides free services to healthcare ecosystem participants including networking support, project development, innovation facilitation, and settlement/expansion consulting. The organization is jointly managed by Berlin Partner für Wirtschaft und Technologie and Wirtschaftsförderung Brandenburg (WFBB), with funding from EFRE and the State of Brandenburg.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

HealthCapital Berlin-Brandenburg is a publicly-supported cluster management organization for the healthcare economy in the Berlin-Brandenburg region, jointly operated by Berlin Partner für Wirtschaft und Technologie and Wirtschaftsförderung Brandenburg (WFBB). It provides free networking, project development, innovation facilitation, settlement and expansion consulting, and event coordination services to biotech companies, research institutions, clinics, and investors across the Biotech & Pharma, Medtech & Digital Health, and Healthcare sectors.

Product overview

HealthCapital Berlin-Brandenburg is a cluster management organization for the health economy (Cluster Gesundheitswirtschaft) in the Berlin-Brandenburg region, operated by Berlin Partner für Wirtschaft und Technologie and Wirtschaftsförderung Brandenburg (WFBB). Rather than a unified software product, the organization offers a portfolio of services including cluster networking and coordination, industry events (BIO International Convention, GITEX AI Europe, Berlin-BIOTECH Symposium), publications (Life Sciences Report, Masterplan Gesundheit, Interstate Health Reports), ecosystem assessments (Digital Health Ökosystem inventory), and business support services (settlement/expansion assistance, startup support, internationalization). The cluster covers three main sectors: Biotech & Pharma, Medtech & Digital Health, and Healthcare/Versorgung.

Differentiator

Problem solved

Functional benefit

Products and services

• Cluster Management Services Networking, project development, and innovation support for health economy stakeholders in Berlin-Brandenburg, including facilitation of connections between biotech companies, research institutions, hospitals, and investors. Managed by Berlin Partner für Wirtschaft und Technologie and Wirtschaftsförderung Brandenburg (WFBB).
• Events and Conferences Organization and promotion of healthcare industry events including BIO International Convention, GITEX AI Europe, Berlin-BIOTECH Symposium, Patient Monitoring Roundtables, Leibniz Symposia, and various networking and matchmaking events for cluster participants.
• Settlement and Expansion Support Support services for companies looking to establish or expand operations in the Berlin-Brandenburg health region, including expert tips, consulting, site selection guidance, and market entry assistance for healthcare companies and international investors.
• Startup Services Support services for health startups in Berlin-Brandenburg, including networking facilitation, funding and financing information, international business development support, and connections to the broader healthcare ecosystem.
• Internationalization Services International business development services for Berlin-Brandenburg healthcare companies, including delegation trips to international markets (e.g., Singapore for Digital Health/AgeTech via GETA International) and participation in international trade shows (BIO International Convention, GITEX AI Europe, Smart Health Asia).
• Skilled Professionals Support Support for skilled professionals (Fachkräfte) and continuing education (Weiterbildung) in the Berlin-Brandenburg healthcare sector, helping companies recruit and develop specialized talent from the regional and international healthcare workforce.
• Funding and Financing Support Support for healthcare companies and startups in accessing funding and financing opportunities, including information on public grants, subsidies, and investment programs available in the Berlin-Brandenburg region.

Quantifiable outcome

• 760+ actors in Life Sciences directory
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Twelve partnerships are on record, tiered core, flagship and minor.

• Berlin Partner für Wirtschaft und TechnologiecoreStrategic or Co-development PartnerJoint cluster management organization for HealthCapital Berlin-Brandenburg. Berlin Partner für Wirtschaft und Technologie provides the cluster management functions including networking support, consulting for companies and research institutions, and coordination of cluster activities.
• Wirtschaftsförderung Brandenburg (WFBB)coreStrategic or Co-development PartnerJoint cluster management organization for HealthCapital Berlin-Brandenburg. WFBB supports economic development in Brandenburg and coordinates with Berlin Partner for the unified cluster management of the Berlin-Brandenburg healthcare region.
• Charité – Universitätsmedizin BerlincoreStrategic or Co-development PartnerEurope's largest university hospital and central research institution in the Berlin-Brandenburg healthcare ecosystem. Charité collaborates on gene and cell therapies, hosts BIH, and participates in initiatives like the Berlin Center for Gene and Cell Therapies.
• Berlin Institute of Health at Charité (BIH)coreStrategic or Co-development PartnerCentral institution for translating biomedical discoveries into personalized diagnostics and therapies. BIH helped develop Germany's National Strategy for Gene and Cell-Based Therapies and hosts the National Network Office for Gene and Cell-Based Therapies.
• Max Delbrück Center for Molecular Medicine (MDC)coreStrategic or Co-development PartnerContributes expertise in genome editing, single-cell technologies, and cell-based medicine. In 2025, the Helmholtz Association committed €30.8 million to the Center for AI-Accelerated Molecular Innovations in Medicine at the MDC.
• Bayer AGflagshipStrategic or Co-development PartnerJoint initiative partner in the Berlin Center for Gene and Cell Therapies (BC GCT) located adjacent to Bayer's Berlin campus. The center is backed by public investments exceeding €100 million and aims to accelerate gene and cell therapy research into clinical use.
• JOIN4ATMP ConsortiumcoreStrategic or Co-development PartnerEU-funded consortium coordinated by Charité aimed at improving market access and reimbursement pathways for ATMPs (Advanced Therapy Medicinal Products) across Europe.
• Einstein Foundation BerlincoreStrategic or Co-development PartnerSupports the Einstein Center for Early Disease Interception (EC-EDI) which brings together twelve leading institutions in Berlin to identify early molecular biomarkers for neurological and pulmonary diseases.
• T-knife TherapeuticsminorStrategic or Co-development PartnerBerlin-based biotech company developing T-cell receptor-based immunotherapies targeting solid tumors, attracted by the growing gene and cell therapy network in Berlin-Brandenburg.
• EpiBlock TherapeuticsminorStrategic or Co-development PartnerBiotech company advancing a gene therapy approach for epilepsy, part of the growing network of companies in Berlin's advanced therapy ecosystem.
• Enterprise Europe Network (EEN)coreGTM or Marketing PartnerInternational partnering network facilitating matchmaking at events like GITEX AI EUROPE 2026, connecting tech leaders, founders, researchers and innovation drivers across Europe.
• DUCAH eG (Digital Urban Center for Aging and Health)coreStrategic or Co-development PartnerOrganizes international delegation trips like GETA International to Singapore for Digital Health/AgeTech, facilitating connections between Berlin health companies and international markets.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Flanders.bio: Flemish biotech cluster association serving a comparable role as networking and representation body for biotech/medtech companies in Belgium, with similar membership and event activities.
• Medicon Village: An internationally prominent life sciences innovation campus in the Medicon Valley (Sweden/Denmark) offering cluster-style services around research parks, biotech tenants, and academic-industry collaboration.
• Basel Area Business & Innovation: Cluster promotion and settlement agency for the Basel region — a leading European pharma hub running a directly comparable 'attract and support life sciences companies' mandate for a competing European cluster.

Others

• EIT Health: EU-funded pan-European health innovation partnership of universities, companies, and clusters — an ecosystem-level partner with overlapping membership in Berlin-Brandenburg institutions and directly comparable digital health and ATMP acceleration programs.

Direct peers

• Life Science Nord Management GmbH: Manages the northern German life sciences cluster across Hamburg and Schleswig-Holstein with comparable cluster-management mandate, member directory, and industry-event programming for pharma/medtech companies.
• BioM Biotech Cluster Development GmbH: Cluster management organization for the Bavarian biotech/medtech ecosystem centered on Munich — the most direct German counterpart to Berlin-Brandenburg's HealthCapital, providing analogous networking, settlement support, and funding guidance services to biotech startups.
• BioRegioN Management GmbH: Cluster development entity for Lower Saxony's life sciences sector, providing analogous networking, funding, and startup-support services to biotech and medtech companies in Niedersachsen.
• Medical Valley EMN e.V. Cluster management organization for medical technology in the Erlangen-Nürnberg metropolitan region operating a comparable public-private cluster model with research-hospital and industry coordination focus.

Broad incumbents

• Innovate UK / Catapult Network: UK government-backed innovation and cluster funding bodies for life sciences, precision medicine, and digital health — comparable public-mandate entities that bridge research, industry, and capital.
• Massachusetts Life Sciences Center: Public-private quasi-governmental organization that promotes and funds life sciences growth in Massachusetts — a more mature analog to HealthCapital, scaled to one of the largest global life sciences clusters.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/showcase/healthcapital-berlin-brandenburg
• Xx.com/healthcapitalbb

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HealthCapital Berlin-Brandenburg